Parliamentary QA
Number of People Developing Severe Allergic Reactions after First Dose of mRNA COVID-19 Vaccine and Advised not to proceed with Second Dose
13 September 2021
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Name and Constituency of Member of Parliament
Dr Lim Wee Kiak
MP for Sembawang GRC
Question No. 1536
To ask the Minister for Health (a) to date, how many people have developed severe allergic reactions after their first dose of an mRNA vaccine; (b) how many have been advised against proceeding with the second dose; and (c) what is the vaccination plan for this group.
Written Answer
As of 10 September 2021, 47 persons were notified to the Health Sciences Authority (HSA) as having anaphylaxis, a severe allergic reaction, after their first dose of an mRNA vaccine. All such persons are unsuited to take subsequent doses of mRNA vaccines.
They are offered Sinovac-CoronaVac (Sinovac) in public hospitals, to complete their vaccinations. Alternatively, they may choose to wait for the other non-mRNA vaccines that MOH has procured and expects to be delivered by the end of the year or early next year.